
Gilead Sciences announced on Sunday that the UAE Ministry of Health and Prevention had granted regulatory approval for the coronavirus drug remdesivir. The drug was approved as an emergency medicine to treat those suffering from COVID-19 infection, a statement read.
The approval was given following clinical data obtained in a trial by the US National Institute of Allergy & Infectious Diseases (NIAID).Washington authorized the emergency use of the medicine – which was originally intended as a treatment for Ebola – on May 1, followed by several Asian nations including Japan and South Korea.
The green light comes on the recommendation of the European Medicines Agency which gave its conditional authorization last week for the treatment of patients above 12 years of age who are suffering pneumonia and require extra oxygen. It said its assessment was also mainly based on data from the NIAID study. The research, published in the leading journal the New England Journal of Medicine in May, showed that injections of Remdesivir speeded patient recovery compared with a placebo.
On average it reduced patients’ hospital stays from 15 days to 11.
Comments
Read Next
Kuwait: Over 35,000 vaccinated in one month
Kuwait registers 505 coronavirus cases and 3 deaths
Saudi Arabia reports 223 new virus cases, 4 deaths
UAE reports 3,601 new coronavirus cases and 7 deaths
Abu Dhabi requires entry PCR tests for truck drivers
Bahrain: Covid patient in trial for refusing to disclose contacts’ details
Oman: COVID-19 caseload reaches 133,253
Kuwait records 492 positive cases; 2 deaths
UAE: Uber offers discounts on rides for COVID-19 vaccinations
UAE: New Covid test requirements for unvaccinated employees
Related Articles
- UAE stops dental, cosmetic procedures2 days ago